pharmaphorum

DECEMBER 14, 2022

But increased competition is on the horizon. Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. Competition starts to heat up. Classic treatment options.

Competition 91

Competition FDA Pharmaceutical Marketing 91

European Pharmaceutical Review

SEPTEMBER 1, 2023

OTX-2002 from Omega Therapeutics is an mRNA therapy anticipated to generate $658 million in global sales, representing 33.2 Omega Therapeutics’s share suggests increasing competition and diversification in this innovative field,” concluded Podder. percent of the total mRNA therapy market by 2029.

Marketing 92

Marketing Sales Competition Pharmaceutical 92

pharmaphorum

AUGUST 24, 2022

Indivior has failed in its bid to prevent a lawsuit claiming that it illegally blocked competition to opioid addiction drug Suboxone from coming to court in the US. Indivior made an application for a judgment in its favour without coming to trial, but that has been denied by Judge Mitchell Goldberg in a Philadelphia court. .”

Competition 52

Competition Marketing Healthcare Healthcare 52

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4

Safety 113

Safety Medicine Competition Networking 113

PharmaKinnex

AUGUST 23, 2022

Let’s dive into the current state of the pharma industry and learn more about what your team can do to stay ahead of the curve and the competition. PharmaKinnex’s multi-channel marketing approach gets the message across with clarity and consistency, breaking through the noise of the competition. Sources: [link].

Pharma 52

Pharma Sales Sales Strategy Marketing 52

PM360

APRIL 7, 2023

Biopharma companies that prioritize in-person patient engagement, supported by digital and social channels, will be better positioned to meet the needs of patients and thrive in an increasingly competitive landscape. John Benjamins Publishing, 2002. Let’s bring back the power of in-person meetings and create meaningful connections.

Biopharma 52

Biopharma Patients Specialization Networking 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Enzymatic production of cyclodextrins, Applied Microbiology and Biotechnology , 2002, 59, 609-617. Lithium, due to its smaller radius and high polarising strength, can replace Na + and K + in α-CD. percent and 7.5=

Electronics 91

Electronics Food Pharmaceutical Doctors 91